Form 8-K - Current report:
SEC Accession No. 0001213900-19-025038
Filing Date
2019-11-29
Accepted
2019-11-29 16:13:38
Documents
2
Period of Report
2019-11-25
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k112519_inmunebio.htm 8-K 29916
2 PRESS RELEASE DATED NOVEMBER 25, 2019 f8k112519ex99-1_inmunebio.htm EX-99.1 17976
  Complete submission text file 0001213900-19-025038.txt   49231
Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 191261369
SIC: 2836 Biological Products, (No Diagnostic Substances)